Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients-Reference-Cited by-同舟云学术

Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients

Published:2000-09 Issue:3 Volume:56 Page:393-398
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

de la Taille Alexandre,Katz Aaron,Cao Yichen,McKiernan James,Buttyan Ralph,Burchardt Martin,Burchardt Tatjana,Hayek Omar,Olsson Carl A,Chopin Dominique K,Sawczuk Ihor S

Publisher

Elsevier BV

Subject

Urology

Reference24 articles.

1. Molecular prognostic factor in renal cell carcinoma;Shimazui;Semin Urol Oncol,1996

2. de la Taille A, Buttyan R, McKiernan J, et al: Biomarkers in renal cell carcinoma: past and future consideration. Urol Oncol (in press).

3. Expression of the tumor-associated gene MN;McKiernan;Cancer Res,1997

4. The detection of renal cancer cells in the peripheral blood via an enhanced RT-PCR assay for MN/CA9;McKiernan;Cancer,1999

5. de la Taille A, Cao Y, Buttyan R, et al: Prostate-specific membrane antigen (PSMA) expression in kidney tissues and in peripheral blood of renal cancer patients: a biomarker of vascular invasion. Cancer Detect Prev (in press).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of FOLH1 Expression in Renal Cell Carcinoma;Cancers;2024-05-13

2. MN/CA9 gene expression as a potential tumor marker for renal cell carcinoma;Molecular and Cellular Biochemistry;2021-10-30

3. Circulating tumor cell detection methods in renal cell carcinoma: A systematic review;Critical Reviews in Oncology/Hematology;2021-05

4. Speckle-type POZ protein as a diagnostic biomarker in renal cell carcinoma;Journal of Cancer Research and Therapeutics;2018

5. Combination of mTOR and MAPK Inhibitors—A Potential Way to Treat Renal Cell Carcinoma;Medical Sciences;2016-10-17